The nuclear medicine department of the fourth hospital of Hebei Medical University and Hebei cancer hospital was established earlier in Hebei Province, with a history of more than 40 years. The construction area of nuclear medicine discipline is more than 3000 square meters, including one hospital and two districts, the headquarters and the East Hospital, and the unified management of human resources and materials, which has built a rapid development platform for the development of departments. At present, the Department has 23 formal staff, 1 senior, 4 deputy senior and 7 middle-level staff. The title structure and talent echelon are reasonable. 32 graduates and 13 doctoral students have been trained. At present, there are 1 PET / CT, 3 SPECT / CT, 1 SPECT, 2 radioimmunoassay, 1 chemiluminescence and 1 bone densitometer and other large-scale equipment, with complete and advanced protective equipment. The nuclear medicine diagnosis and treatment projects are complete, including functional molecular imaging diagnosis, nuclide treatment, radioimmunoassay, chemiluminescence, bone mineral density examination, etc. Our hospital has advanced technology and rich experience in nuclear medicine facilities. It is at the domestic advanced level in terms of the number of patients and business income at the diagnosis and treatment level and the provincial leading level.
In 2007, the first pet / CT - gimini 16 PET / CT in Hebei Province was set up in the fourth hospital of Hebei Medical University, which opened a new chapter of molecular imaging diagnosis in Hebei Province. In 2011 and 2013, we took the lead in introducing the most advanced discovery nm / CT 670 SPECT / CT, and in 2018, we introduced quantitative nm / CT 670 SPECT / CT equipment. On October 9, 2019, it was approved by the national health and Health Commission to purchase the first pet / MR in Hebei Province.
At present, the diagnosis and treatment projects carried out by the Department mainly include: molecular imaging diagnosis, staging and re staging of PET / CT whole body tumor, efficacy evaluation; whole body bone imaging and SPECT / CT diagnosis of bone metastasis, parathyroid adenoma, etc.; 131 iodine whole body imaging, sentinel lymph node detection and location of breast cancer, renal function imaging to understand renal function, thyroid imaging to identify the nature of thyroid nodules; bone metastasis Tumor nuclide therapy, differentiated thyroid cancer 131 iodine therapy, hyperthyroidism 131 iodine therapy, skin hemangioma application therapy, etc. Detection of trace substances such as tumor markers, bone mineral density, etc. PET / MR molecular imaging diagnosis will be carried out.
Nuclear medicine department is the key medical discipline (image) of Hebei Province, and the awarding unit of doctor's degree of medical image and nuclear medicine of Hebei Medical University. The Department has made great progress under the leadership of Professor Zhao Xinming, department director, discipline leader and doctoral supervisor.
The Department has undertaken 2 National Natural Science Foundation projects, 1 international cooperation project, 1 Beijing Tianjin Hebei cooperation major project, Hebei Natural Science Foundation and Provincial Bureau and many other projects. It has won one second-class scientific and technological achievements, three third-class scientific and technological achievements at the provincial and ministerial levels, and many scientific and technological achievements at the level of departments and bureaus. Edited 1 academic monograph and participated in 8. He has published more than 100 academic papers in jnm, BJR, cancer BiotHER radio, enmmi and Chinese Journal of nuclear medicine and molecular imaging.
entification of Rh blood group system, screening and identification of irregular antibodies, Coomb ` s test, hemolysis test of newborn, cross matching test (microcolumn method and coagulum method), identification of difficult blood groups, blood irradiation and detection of syphilis and AIDS antibody. Projects to be carried out: plasma exchange, single collection, platelet antibody, blood coagulation and platelet function detection, and clinical application of platelet rich plasma technology.
On May 14, 2019, the blood transfusion department moved to the new site. In response to the call of the hospital, the blood transfusion department implemented 5S management in an all-round way. In order to better serve patients and clinical departments, the Department carried out the project from the original single blood group serology detection technology to clinical blood transfusion treatment.
